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Evaluation of newer methods and optimization of existing methods for the susceptibility
testing of second-line drugs, especially ethionamide, are essential when treatment of
multidrug-resistant tuberculosis (MDR-TB) is warranted. The ideal method must clearly
demarcate sensitive from resistant strains. Hence, optimization of the conventional
minimum inhibitory concentration (MIC) method was attempted using diluted inoculum.
The optimized MIC method was evaluated using 206 Mycobacterium tuberculosis strains
isolated from new and previously treated tuberculosis patients and were compared with
the conventional MIC method and proportion sensitivity (PST) method. The sensitivity
and specificity of the optimized MIC method in comparison with the PST method was
74% and 90%. Assessment of the optimized MIC method with the conventional MIC method
gave a sensitivity of and specificity of 73% and 98%. Overall agreement between the
zmethods was found to beP80%. Endowed with the ability to identify the resistant strains
precisely, the optimized MIC method can be used for screening resistance to ethionamide.
 2013 Asian-African Society for Mycobacteriology. All rights reserved.Introduction
Emergence of multidrug-resistant Mycobacterium tuberculosis
(MDR-TB) is of great epidemiological concern, especially in
tuberculosis (TB) endemic settings like India [1]. The esti-
mated proportion of MDR-TB worldwide is 2.9% and 15.3%
from new and previously treated cases [2]. Ethionamide
(ETO) is used in programmatic management of drug-resis-
tant tuberculosis (PMDT) under the Revised National TB Con-
trol Programme (RNTCP) for the treatment of multidrug
resistant TB (MDR-TB) [3]. Therefore, determination of a sus--African Society for Myco
528.
o.in (V. Kumar).ceptibility profile for ETO is warranted for effective monitor-
ing and customized treatment. An accurate method for drug
susceptibility testing (DST) of this thermo labile drug has
been difficult to establish because the difference in mini-
mum inhibitory concentration (MIC) associated with resis-
tance is minimum. Hence, the distribution of probable
sensitive and resistant strains is not well separated [4,5]
leading to a discrepancy between MIC values of ETO and
the clinical outcome of patients. Efforts are required to
revisit the MIC values at regular intervals to ascertain the
breakpoint concentration. Another approach is to validatebacteriology. All rights reserved.
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same. Herein the optimization of the existing conventional
MIC method for ethionamide by using diluted inoculum
(1 lg/ml) is reported.
Materials and methods
A total of 235 M. tuberculosis strains isolated from new and
previously treated TB patients were subjected to DST for
ETO by MIC and PST methods following standard procedure
[6,7]. Briefly, one-third loopful of 2–3 week-old culture on
Lowenstein–Jensen (LJ) media was suspended in 1 ml of ster-
ile distilled water and vortexed to obtain an even suspension
of 4 mg/ml. The coarse particles or clumps in the suspension
were allowed to settle at room temperature; 10 microliters of
the suspension was inoculated onto drug and drug-free LJ
medium. The concentration of the ETO used was 20, 28.5,
40, 57, 80, 114 and 156 lg/ml. The inoculum concentration
used for conventional MIC (4 mg/ml) was diluted using ster-
ile distilled water to obtain diluted inoculum of 1 mg/ml con-
centration. Susceptibility testing for ETO using diluted
inoculum at the above-mentioned drug concentrations was
performed by the conventional MIC method described above.
Tenfold dilution from 1 mg/ml concentration was prepared
by adding 0.2–1.8 ml sterile distilled water (S1, 101). Two fur-
ther serial dilutions 102 (S2) and 103 (S3) were prepared in
a similar manner. Ten microliters from each of the above
dilutions were inoculated onto drug-free and drug-containing
LJ slopes (40 lg/ml of ethionamide). Susceptibility testing was
carried out at the same time point using the same batch med-
ia to avoid any error. Results were read after 28 days and
42 days of incubation at 37 C for MIC and PST methods
respectively.
Interpretation of conventional and optimized MIC methods
Isolates withP20 colony counts (1+ grading) were considered
resistant to the particular drug concentration of ETO. The col-
ony count for determining resistance was kept equal for both
methods. Break point MIC value for defining resistance in the
conventional MIC method was P80 lg/ml and values less
than that were considered susceptible.
Interpretation of PST method
Isolates with more than 1% of colony forming units (CFU) in
drug-containing LJ slopes in comparison with drug-free LJ
slopes were considered as resistant by the PST method. Iso-
lates with values less than 1% criteria defining resistance
were considered as susceptible. Isolates with PST values be-
tween 0.9% and 1.1% were considered as ‘‘borderline’’.Table 1 – Pattern of MIC values obtained for ethionamide by op
Minimum inhibitory concentration (in lg/m
20 28.5 40 57
No. of strains 27 10 31 34Errors
The presence of false resistance or susceptibility is considered
as errors in any method [8]. False resistance (FR) is classified
as major error (ME), which does not have any major implica-
tions with respect to treatment of patients. But false suscep-
tibility (FS) is considered to be very major error (VME) as it
guides improper treatment for the patient.
Laboratory susceptible strain H37Rv was used as a control
on a daily basis. The results were analyzed by Chi Square test
using SPSS software version 17.0.Results
Two hundred and six isolates out of 235 M. tuberculosis strains
had valid results in DST for ETO by conventional MIC, opti-
mized MIC and PST methods. The pattern of susceptibility ob-
tained by the optimized MIC method showed a varied
distribution of isolates along the drug concentrations used
(Table 1). The presence of isolates with resistance more than
the highest concentration (114 lg/ml) routinely used in DST
for ETO was observed. The standard strain H37Rv showed a
susceptible result during the DST time line.
It was re-determined that 80ug/ml was the most appropri-
ate breakpoint minimum inhibitory concentration for the
conventional MIC method (communication under process).
Since the optimized MIC method uses diluted inoculum, use
of the same breakpoint concentration (80 lg/ml) needs to be
assessed. The susceptibility pattern for the optimized MIC
method with breakpoint MIC values at 80, 114 and 156 lg/ml
were analyzed and compared with the PST and the conven-
tional MIC methods.Evaluation of the optimized MIC method with the PST method
The optimized MIC method was compared with the ‘‘stan-
dard’’ PST method for 206 isolates; 4 isolates that showed bor-
derline PST values were eliminated. Agreement between the
optimized MIC method at 80 lg/ml and the PST method was
found to be superior (kappa value – 0.590) to 114 and
156 lg/ml (Table 2). An increase in the number of VME was
observed with an increase in breakpoint concentration from
80 to 114 and 156 lg/ml. As expected, the ME was found to de-
crease with an increase in the breakpoint concentration.
Although slightly improved specificity was observed with
increasing breakpoint concentrations, by overall comparison
with the PST method, 80 lg/ml was found to be the ‘‘effec-
tive’’ breakpoint concentration for the optimized MIC
method.timized MIC method.
l) Total
80 114 156 >156
24 31 20 29 206
Table 2 – Evaluation of Optimized MIC method with PST method (at 40 lg/ml).
Optimized MIC value Susceptibility profile PST method at 40 lg/ml Total
Resistant Susceptible
P80 lg/ml Resistant 97 7 104
680 lg/ml Susceptible 34 64 98
Total 131 71 202
Sens: 74%; Spec: 90%;
PPR: 93%; PPS: 65%; Accuracy:
80%; kappa: 0.590 (moderate);
CI(95%): 0.483–0.698
P114 lg/ml Resistant 75 5 80
6114 lg/ml Susceptible 56 66 122
Total 131 71 202
Sens: 57%; Spec: 93%; PPR: 94%;
PPS: 54%; Accuracy: 68%; kappa: 0.431
(moderate); CI(95%): 0.326–0.537
P156 lg/ml Resistant 48 1 49
6156 lg/ml Susceptible 83 70 153
Total 131 71 202
Sens: 37%; Spec: 99%;
PPR: 98%; PPS: 46%;
Accuracy: 57%, kappa: 0.279 (fair);
CI(95%): 0.194–0.363
MIC value: the MIC value obtained equal, less or more than the specified concentration; PST – proportion sensitivity testing; Sens – sensitivity;
Spec – Specificity; PPR/PPS – positive predictive value for resistance/susceptible; CI – confidence interval at 95%.
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conventional MIC method
The minimum inhibitory concentration of 206 isolates ob-
tained by the conventional MIC method and the optimized
MIC method was compared. When the breakpoint MIC was
arbitrarily set at 80 lg/ml, a single FR result was noted by
the optimized MIC method (Table 3). However, various break-
point concentrations were analyzed for the optimized MIC
method in comparison with the conventional MIC method
at 80 lg/ml (Table 4). The predictive value for resistance was
higher when the MIC was set at 80 lg/ml than at the other
two concentrations. When the MIC for the optimized MIC
method was set at 80 lg/ml, a single FR and 39 FS were ob-
served with a kappa value of 0.610. Though the statistical val-
ues at MIC (156 lg/ml) were higher, the ME and the VME wereTable 3 – Comparison of MIC values obtained by conventional a
Optimized MIC method (in lg/ml) Conventional MIC meth
620 28.5 40
620 8 9 5
28.5 1 1 2
40 0 1 4
57 0 1 2
80 0 0 0
114 0 0 0
156 0 0 0
>156 0 0 0
Total 9 12 13
MIC value: the MIC value obtained equal, less or more than the specifiedmore than that observed at 80 lg/ml. Results of MIC at 114 lg/
ml indicated more or less an even distribution of ME and VME.
Discussion
Ethionamide is used in the treatment of MDR-TB under
RNTCP [9]. Therefore, it becomes necessary to verify or, if re-
quired, re-standardize the susceptibility testing method for
the drug. Effective drug action and discrimination of resis-
tant and susceptible isolates can be observed whenever the
MIC of the drug is well below its therapeutic index [10].
The MIC of ETO is very close to its therapeutic index espe-
cially in solid LJ medium, thus increasing the chance of addi-
tional resistance [5]. It is known that some variation in MIC
for ETO is expected in different laboratories and also with
respect to time intervals [6] which can be attributed to and optimized MIC methods.
od (in lg/ml) Total
57 80 114 156 >156
5 0 0 0 0 27
5 0 1 0 0 10
14 11 1 0 0 31
5 12 11 3 0 34
0 7 9 5 3 24
0 0 5 15 11 31
1 0 1 13 5 20
0 0 1 1 27 29
30 30 29 37 46 206
concentration.
Table 4 – Evaluation of MIC values between conventional and optimized MIC methods.
Optimized MIC value Susceptibility profile Conventional MIC method at 80 lg/ml Total
Resistant Susceptible
P80 lg/ml Resistant 103 1 104
680 lg/ml Susceptible 39 63 102
Total 142 64 206
Sens: 73%; Spec: 98%; PPR:99%; PPS: 62%; Accuracy: 81%; kappa: 0.610 (good); CI(95%): 0.509–0.711
P114 lg/ml Resistant 50 30 80
6114 lg/ml Susceptible 25 101 126
Total 75 131 206
Sens: 67%; Spec: 77%; PPR: 63%; PPS: 80%; Accuracy: 73%; kappa: 0.432 (moderate); CI(95%): 0.305–0.558
P156 lg/ml Resistant 32 17 49
6156 lg/ml Susceptible 14 143 157
Total 46 160 206
Sens: 70%; Spec: 89%; PPR: 65%; PPS: 91%; Accuracy: 85%; kappa: 0.576 (moderate); CI(95%): 0.443–0.709
MIC value: the MIC value obtained equal, less or more than the specified concentration; Sens – sensitivity; Spec – specificity; PPR/PPS – positive
predictive value for resistance/susceptible; CI – confidence interval at 95%.
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circulating within the geographical region. Such differences
may contribute to the disparity between in vivo and in vitro
drug susceptibility profiles, thus hampering effective treat-
ment [11].
Considering the above facts, this study attempted to revisit
the existing methodology with a novel approach by diluting
the inoculum used for the conventional MIC methodology.
The assumption was whether enhanced discrimination be-
tween resistant and susceptible isolates can be achieved by
diluting the inoculum rather than using a concentrated inoc-
ulum of 4 mg/ml. As expected, a decrease in the culture grad-
ing in drug-free as well as in drug-containing slopes was
observed using a diluted inoculum compared to that of the
conventional method, which was consistent (data not
shown). Awide distribution of isolates with different MIC val-
ues is an indicator of robustness and applicability of the con-
ventional MIC method even if modifications are introduced.
A slight decrease in the sensitivity of the optimized format
in comparison with the conventional MIC (73%) and the PST
(74%) methods can be attributed to the presence of false sus-
ceptible isolates. Out of 73 VME isolates from both conven-
tional MIC and PST methods, 65 isolates had their MIC
values distributed at 57 and 40 lg/ml. Isolates with greater
deviation in MIC either on the higher or lower scale was lim-
ited. Reasons for the VME may be the dilution effect on the
inoculum. There exists a possibility to miss the resistant pop-
ulation if present in fewer quantities. Use of a higher inocu-
lum might sometimes indicate a ‘‘high’’ rate of resistant
phenotype that may not be a true resistant at all times and
interference of clumps becomes inevitable [12].
Seven isolates were classified as ME by the optimized MIC
method when compared with the PST method. Four of these
had an MIC value of 114 lg/ml, a single isolate had a value
of 156 lg/ml and the remaining two isolates had an MIC of
80 lg/ml. The reason for the presence of MEmay be attributed
to a technical defect, especially during the inoculation pro-
cess. A nichrome wire loop with a 3 mm diameter that is able
to deliver 10 ll is used for inoculation onto LJ slopes. Though
the method is standardized and has been used for decades inthis laboratory, sometimes an error occurs when the inocu-
lum size is increased and such fault can be rectified.
Errors (ME and VME) could also be due to the presence of
‘‘borderline’’ isolates in both the methods. Such isolates tend
to indicate varying susceptibility patterns at each episode.
Molecular analysis of these ME and VME isolates might ex-
plain the reasons for a discrepancy, if any, and involvement
of single or multiple genes associated with resistance. The
involvement of more than one gene conferring resistance,
as in drugs like streptomycin and isoniazid, could be one of
the reasons for the presence of ‘‘borderline’’ resistant isolates.
The exact mechanism of resistance for ETO has not yet been
fully deciphered, but the inhibition of fatty acid synthesis was
identified as the drug target inM. tuberculosis [13–15]. It is also
speculated that resistance to ETO might be mediated through
multiple genes and thus can have ‘‘borderline’’ resistant iso-
lates [11,16–17].
It is expected that an ideal method should provide results
similar or better than the other methods available. However,
it should be noted that variations arising due to differences
in the methodology still remains and they play a vital role
in determining the accuracy of the method. Such variations
lead to the presence of errors. The minimum inhibitory con-
centration method determines or measures the level of the
drug that can be used for effective treatment whereas PST
measures the population of the bacteria that overcome the ef-
fect of the drug. There exists a variation in the basis between
these methods defining resistance [5].
Varying inoculum size was not compared with the conven-
tional method because the optimized format is the initial
dilution (S1 dilution according to RNTCP manual [18]) used
in the proportion sensitivity testing (PST) method, which is
a qualitative DST method. When the concentration of inocu-
lum is still reduced (1 in 10 dilution of optimized format), col-
ony counts will further decrease. In such cases, an effective
comparison could be obtained and results in these inoculum
concentrations may not depict ‘‘true’’ susceptibility to the MIC
method.
The optimized methodology is validated using different
patient populations comprising new patients, patients
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for MDR-TB. With overall high accuracy, the optimized meth-
od can also be used as an alternative to the conventional MIC
method to determine the susceptibility profile of ETO. The
optimized method can be used in resource-limited settings
where DST is still performed on LJ medium. There is no cost
reduction by using this optimized format, but it could provide
a better demarcation between resistant and susceptible iso-
lates. The proportion sensitivity testing method is being per-
formed for patients enrolled for treatment of MDR-TB. The
use of an optimized format might prove to be a better alterna-
tive for the existing methodology and results can be obtained
2 weeks earlier than the PST method. Any strain identified as
resistant by the optimized method can be considered as such
without any further confirmation. However, susceptible iso-
lates need to be reconfirmed, preferably using liquid culture
systems like MGIT 960.
Conclusion
The present study is a novel attempt to optimize the widely
used MIC method for susceptibility testing of ethionamide,
one of the second-line drugs used in MDR-TB treatment in
the country. For drugs that confer uncertain DSTresults, there
arises a need for a method that can effectively discriminate
the susceptible and resistant isolates. The study indicates
that the optimized format of the conventional MIC method
can be used for susceptibility testing. However, stringent dilu-
tion might enhance the efficiency of the method.Conflict of interest
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